Article
Cisplatin exposure dysregulates pancreatic islet function in male mice
2024-09-26
Abstract excerpt
Cancer survivors have an increased risk of developing new-onset Type 2 diabetes compared to the general population. Moreover, patients treated with cisplatin, a commonly used chemotherapeutic agent, are more likely to develop metabolic syndrome and Type 2 diabetes compared to age- and sex-matched controls. Insulin-secreting beta cells—located within pancreatic islets—are critical for maintaining glucose homeostasi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e1382be4-c8ba-573f-b21e-0988d156160e
- DOI
- 10.1101/2024.09.25.614996
